← Back to headlines
Monod Bio Licenses AI-Designed Protein Technologies to SignalChem Biotech
Monod Bio has entered a licensing agreement with SignalChem Biotech to utilize its AI-designed protein technologies for custom discovery assays.
26 Aug, 12:33 — 26 Aug, 12:33
Related Stories
Hungary’s Paks Nuclear Plant Returns to Full Power Output Ahead of Schedule
14m ago
Jennifer Garner Reveals Career Anxiety and Financial Fears Following Divorce
23m ago
Nigerian Government and Student Union Criticize Atiku’s Push to Restore Fuel Subsidies
44m ago
Meta Agrees to $18 Billion Settlement in Child Social Media Addiction Lawsuits
50m ago